Docking Study to Predict the Efficacy of Phosphatidylinositol 3-Kinase α Inhibitors

Docking Study to Predict the Efficacy of Phosphatidylinositol 3-Kinase α Inhibitors

The phosphatidylinositol 3-kinase (PI3K) family comprises lipid kinases that cross-link signals between living cells and their surroundings. PI3Ks are classified into several groups and isoforms with specific characteristics and functions. Genes encoding PI3Ks are mutated in several types of cancer,...

Full description

Bibliographic Details
Main Authors:	Mahmoud A. Chawsheen, Hazem A. Al-Bustany
Format:	Article
Language:	English
Published:	Koya University 2019-12-01
Series:	ARO-The Scientific Journal of Koya University
Subjects:	autodock vina, cancer cell, cell signaling, docking, phosphatidylinositol 3-kinase, phosphatidylinositol 3-kinase α
Online Access:	http://aro.koyauniversity.org/article/view/565

Similar Items

Mitigation of acetaminophen-induced liver toxicity by the novel phosphatidylinositol 3-kinase inhibitor alpelisib
by: Mohamed E. Shaker, et al.
Published: (2023-08-01)

Corrigendum: Mitigation of acetaminophen-induced liver toxicity by the novel phosphatidylinositol 3-kinase inhibitor alpelisib
by: Mohamed E. Shaker, et al.
Published: (2023-09-01)

The Role of Phosphatidylinositol Phosphate Kinases during Viral Infection
by: Anne Beziau, et al.
Published: (2020-10-01)

Differential Effects of Phosphatidylinositol 4-Kinase (PI4K) and 3-Kinase (PI3K) Inhibitors on Stomatal Responses to Environmental Signals
by: Koh Iba, et al.
Published: (2017-05-01)

Inhibition of Phosphatidylinositol 3-Kinase by Pictilisib Blocks Influenza Virus Propagation in Cells and in Lungs of Infected Mice
by: Stefanie Deinhardt-Emmer, et al.
Published: (2021-05-01)

Berberine ameliorates renal impairment and inhibits podocyte dysfunction by targeting the phosphatidylinositol 3‐kinase–protein kinase B pathway in diabetic rats
by: Wei‐Jian Ni, et al.
Published: (2020-03-01)

Therapeutic Effect of a Novel Phosphatidylinositol-3-Kinase δ Inhibitor in Experimental Epidermolysis Bullosa Acquisita
by: Hiroshi Koga, et al.
Published: (2018-07-01)

Phosphatidylinositol 3‐monophosphate: A novel actor in thrombopoiesis and thrombosis
by: Colin Valet, et al.
Published: (2020-05-01)

Novel Mechanism for an Old Drug: Phenazopyridine is a Kinase Inhibitor Affecting Autophagy and Cellular Differentiation
by: Olivier Preynat-Seauve, et al.
Published: (2021-08-01)

Effects of combined therapy of Phosphatidylinositol 3p-Kinase and Paclitaxel in human lung cancer nude mice model
by: Yajuan REN, et al.
Published: (2008-04-01)

Accelerating AutoDock Vina with GPUs
by: Shidi Tang, et al.
Published: (2022-05-01)

Herpesviruses in the Activated Phosphatidylinositol-3-Kinase-δ Syndrome
by: Jeffrey I. Cohen
Published: (2018-02-01)

Development of A. solani β-tubulin models and comparison of docking results for benzo[d]azoles derivatives as potential antifungal agents
by: Konstantin L. Obydennov, et al.
Published: (2024-01-01)

The Role of Class IA Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunits in Glioblastoma
by: Kevin J. Pridham, et al.
Published: (2017-12-01)

Phytochemical analysis and evaluation of antibacterial activity of Moringa oleifera extracts against gram-negative bacteria: an in vitro and molecular docking studies
by: Ganjo Aryan R., et al.
Published: (2022-12-01)

AMDock: a versatile graphical tool for assisting molecular docking with Autodock Vina and Autodock4
by: Mario S. Valdés-Tresanco, et al.
Published: (2020-09-01)

Class I phosphatidylinositol 3-kinase inhibitors for cancer therapy
by: Wennan Zhao, et al.
Published: (2017-01-01)

Evaluation of the binding performance of flavonoids to estrogen receptor alpha by Autodock, Autodock Vina and Surflex-Dock
by: Qiao Xue, et al.
Published: (2022-03-01)

Phosphatidylinositol 3-kinase and COPII generate LC3 lipidation vesicles from the ER-Golgi intermediate compartment
by: Liang Ge, et al.
Published: (2014-11-01)

Immune checkpoint inhibitor– and phosphatidylinositol-3-kinase inhibitor–related diabetes induced by antineoplastic drugs: two case reports and a literature review
by: Yue Gao, et al.
Published: (2023-09-01)

Leniolisib: a novel treatment for activated phosphoinositide-3 kinase delta syndrome
by: Surya K. De, et al.
Published: (2024-02-01)

Phosphatidylinositol 4-kinase is a viable target for the radical cure of Babesia microti infection in immunocompromised hosts
by: Shengwei Ji, et al.
Published: (2022-11-01)

Heterogeneity of Phosphatidylinositol-3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin Activation in Cancer: Is PI3K Isoform Specificity Important?
by: Célia Cintas, et al.
Published: (2018-01-01)

In Vivo and In Vitro Enhanced Tumoricidal Effects of Metformin, Active Vitamin D<sub>3</sub>, and 5-Fluorouracil Triple Therapy against Colon Cancer by Modulating the PI3K/Akt/PTEN/mTOR Network
by: Riyad Adnan Almaimani, et al.
Published: (2022-03-01)

Carbohydrate Kinases: A Conserved Mechanism Across Differing Folds
by: Sumita Roy, et al.
Published: (2019-01-01)

MiR-126-3p inhibits apoptosis and promotes proliferation by targeting phosphatidylinositol 3-kinase regulatory subunit 2 in porcine ovarian granulosa cells
by: Xiaofeng Zhou, et al.
Published: (2020-06-01)

The Performance of Several Docking Programs at Reproducing Protein–Macrolide-Like Crystal Structures
by: Alejandro Castro-Alvarez, et al.
Published: (2017-01-01)

Identifying potential inhibitors of phosphatidylinositol 4,5-bisphosphate 3-kinase: Molecular dynamic insights into the interaction and inhibitory mechanism
by: Taj Mohammad, et al.
Published: (2024-06-01)

Comparing AutoDock and Vina in Ligand/Decoy Discrimination for Virtual Screening
by: Tatiana F. Vieira, et al.
Published: (2019-10-01)

Detection of PI3K Gene Mutations in Endometrial Cancer in Iran
by: Masoumeh Elyasi, et al.
Published: (2012-03-01)

Endobronchial mucosal nodules and actinomycosis in a child with activated phosphatidylinositol 3-kinase delta syndrome (APDS)
by: Kwan Fung Lam, et al.
Published: (2023-01-01)

Activated Phosphatidylinositol 3-Kinase/Akt Inhibits the Transition of Endothelial Progenitor Cells to Mesenchymal Cells by Regulating the Forkhead Box Subgroup O-3a Signaling
by: Zongqi Zhang, et al.
Published: (2015-03-01)

Serine/Threonine Kinase 3-Phosphoinositide-Dependent Protein Kinase-1 (PDK1) as a Key Regulator of Cell Migration and Cancer Dissemination
by: Laura Di Blasio, et al.
Published: (2017-03-01)

Involvement of Phosphatidylinositol 3-kinase in the regulation of proline catabolism in Arabidopsis thaliana
by: Anne-Sophie eLeprince, et al.
Published: (2015-01-01)

Korean Red Ginseng inhibits apoptosis in neuroblastoma cells via estrogen receptor β-mediated phosphatidylinositol-3 kinase/Akt signaling
by: Cuong Thach Nguyen, et al.
Published: (2015-01-01)

PIK3R3, a regulatory subunit of PI3K, modulates ovarian cancer stem cells and ovarian cancer development and progression by integrative analysis
by: Eun Jung Sohn
Published: (2022-06-01)

Phosphatidylinositol 3-kinase-associated protein (PI3KAP)/XB130 crosslinks actin filaments through its actin binding and multimerization properties in vitro and enhances endocytosis in HEK293 cells.
by: Daisuke Yamanaka, et al.
Published: (2016-07-01)

Nuclear Factor-κB Activating Protein Plays an Oncogenic Role in Neuroblastoma Tumorigenesis and Recurrence Through the Phosphatidylinositol 3-Kinase/Protein Kinase B Signaling Pathway
by: Jun Liu, et al.
Published: (2021-01-01)

Ursolic Acid-Regulated Energy Metabolism—Reliever or Propeller of Ultraviolet-Induced Oxidative Stress and DNA Damage?
by: Yuan-Hao Lee, et al.
Published: (2014-08-01)

Quercetin-3-O-β-D-glucuronide inhibits mitochondria pathway-mediated platelet apoptosis via the phosphatidylinositol-3-kinase/AKT pathway in immunological bone marrow failure
by: Le-Min Xia, et al.
Published: (2022-01-01)